Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel oral anti-influenza drug candidate AV5080.
Ivachtchenko AV, Ivanenkov YA, Mitkin OD, Yamanushkin PM, Bichko VV, Shevkun NA, Karapetian RN, Leneva IA, Borisova OV, Veselov MS. Ivachtchenko AV, et al. J Antimicrob Chemother. 2014 Jul;69(7):1892-902. doi: 10.1093/jac/dku074. Epub 2014 Apr 11. J Antimicrob Chemother. 2014. PMID: 24729605
Novel oral anti-influenza prodrug candidate AV5075S.
Ivachtchenko AV, Ivanenkov YA, Mitkin OD, Yamanushkin PM, Bichko VV, Shevkun NA, Mokrushina OV, Nevolina OO, Karapetian RN, Leneva IA, Fedyakina IT, Veselov MS. Ivachtchenko AV, et al. J Antimicrob Chemother. 2014 May;69(5):1311-24. doi: 10.1093/jac/dkt507. Epub 2014 Jan 15. J Antimicrob Chemother. 2014. PMID: 24428978
Discovery of novel highly potent hepatitis C virus NS5A inhibitor (AV4025).
Ivachtchenko AV, Mitkin OD, Yamanushkin PM, Kuznetsova IV, Bulanova EA, Shevkun NA, Koryakova AG, Karapetian RN, Bichko VV, Trifelenkov AS, Kravchenko DV, Vostokova NV, Veselov MS, Chufarova NV, Ivanenkov YA. Ivachtchenko AV, et al. J Med Chem. 2014 Sep 25;57(18):7716-30. doi: 10.1021/jm500951r. Epub 2014 Sep 9. J Med Chem. 2014. PMID: 25148100
Synthesis, inhibitory activity and oral dosing formulation of AV5124, the structural analogue of influenza virus endonuclease inhibitor baloxavir.
Ivashchenko AA, Mitkin OD, Jones JC, Nikitin AV, Koryakova AG, Karapetian RN, Kravchenko DV, Mochalov SV, Ryakhovskiy AA, Aladinskiy V, Leneva IA, Falynskova IN, Glubokova EA, Govorkova EA, Ivachtchenko AV. Ivashchenko AA, et al. Among authors: ivachtchenko av. J Antimicrob Chemother. 2021 Mar 12;76(4):1010-1018. doi: 10.1093/jac/dkaa524. J Antimicrob Chemother. 2021. PMID: 33367751 Free PMC article.
Novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitors.
Koryakova AG, Ivanenkov YA, Ryzhova EA, Bulanova EA, Karapetian RN, Mikitas OV, Katrukha EA, Kazey VI, Okun I, Kravchenko DV, Lavrovsky YV, Korzinov OM, Ivachtchenko AV. Koryakova AG, et al. Among authors: ivachtchenko av. Bioorg Med Chem Lett. 2008 Jun 15;18(12):3661-6. doi: 10.1016/j.bmcl.2007.11.121. Epub 2007 Dec 5. Bioorg Med Chem Lett. 2008. PMID: 18502121
A novel influenza virus neuraminidase inhibitor AV5027.
Ivachtchenko AV, Ivanenkov YA, Mitkin OD, Yamanushkin PM, Bichko VV, Leneva IA, Borisova OV. Ivachtchenko AV, et al. Antiviral Res. 2013 Dec;100(3):698-708. doi: 10.1016/j.antiviral.2013.10.008. Antiviral Res. 2013. PMID: 24416774
In Silico Approaches to the Design of NS5A Inhibitors.
Ivanenkov YA, Veselov MS, Aladinskiy VA, Shakhbazyan AG, Yartseva SM, Majouga AG, Aladinskaya AV, Vantskul AS, Leonov SV, Ivachtchenko AV, Koteliansky VE. Ivanenkov YA, et al. Among authors: ivachtchenko av. Curr Top Med Chem. 2016;16(12):1383-91. doi: 10.2174/1568026616666151120113705. Curr Top Med Chem. 2016. PMID: 26585932 Review.
75 results